These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3212565)

  • 1. [The effect of apressin on the results of the Valsalva test in ischemic heart disease].
    Sivkov SI; Lesniak EA; Khomenko VL
    Sov Med; 1988; (9):9-12. PubMed ID: 3212565
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
    Shevchenko VA
    Vrach Delo; 1983 Oct; (10):8-12. PubMed ID: 6139918
    [No Abstract]   [Full Text] [Related]  

  • 3. [Peripheral vasodilators in the treatment of chronic circulatory failure in ischemic heart disease patients].
    Lipnitskiĭ TN; Sheverda MG; Otkalenko IuK; Brovko AKh; Bogdanov EA
    Vrach Delo; 1986 Aug; (8):5-8. PubMed ID: 3776159
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of heart failure with vasodilators].
    Bolte HD
    Internist (Berl); 1980 Dec; 21(12):753-9. PubMed ID: 6451599
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic treatment with vasodilators of heart failure. I. Hydralazine treatment].
    Dumitriu M; Costică II; Cinteză M; Dăescu L; Bălan C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(4):349-63. PubMed ID: 6150539
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC; Chakraborty S; Mondal M; Bhandari B
    J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of various peripheral vasodilators on tissue circulation in patients with cardiac insufficiency].
    Aliev EB; Almazov II; Malyshev IuM; Makhatadze LN; Zhumambaeva RM
    Ter Arkh; 1982; 54(5):122-6. PubMed ID: 7101173
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systolic intervals in dilated heart insufficiency. Influence of vasodilator treatment].
    González-Juanatey JR; Amaro Cendón A; Vega Fernández M; Gil de la Peña M
    Med Clin (Barc); 1988 Jan; 90(3):93-6. PubMed ID: 3280894
    [No Abstract]   [Full Text] [Related]  

  • 9. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
    Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B
    G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186
    [No Abstract]   [Full Text] [Related]  

  • 10. [The apex cardiogram as a means of early diagnosis of cardiac insufficiency].
    Fotiade B; Ciobanu M; Protopopescu R; Nestor G; Milcu V; Maximilian V
    Med Interna (Bucur); 1973 Sep; 25(9):1049-64. PubMed ID: 4275795
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vasodilator therapy in management of chronic heart failure (author's transl)].
    Letac B; Champoud O; Moore N
    Therapie; 1981; 36(1):1-10. PubMed ID: 7015550
    [No Abstract]   [Full Text] [Related]  

  • 12. [Features and treatment of heart failure in old age].
    Hess T
    Ther Umsch; 1981 Jan; 38(1):39-48. PubMed ID: 7281050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Have vasodilators improved the prognosis of cardiac failure?].
    Vacheron A
    Arch Mal Coeur Vaiss; 1986 Feb; 79(2):141-2. PubMed ID: 3085616
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modern vasodilator medication in refractory cardiac insufficiency].
    Stanciu L; Branea I; Riviş I; Radivoievici A; Mancaş S; Păunescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):129-34. PubMed ID: 6139858
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasodilators for chronic congestive heart failure.
    Med Lett Drugs Ther; 1984 Dec; 26(677):115-6. PubMed ID: 6390110
    [No Abstract]   [Full Text] [Related]  

  • 17. The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.
    Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI1-4. PubMed ID: 8500232
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution].
    Artese D; Albani A; Di Tomasso E
    Minerva Med; 1983 Mar; 74(13):715-22. PubMed ID: 6220231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 1. Epidemiological situation of coronary heart disease].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1853-64. PubMed ID: 4480270
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of cardiac insufficiency with systemic vasodilator agents].
    García Puig J; Gil Aguado A; Arnalich F; Gaspar G; Anciones B; Vázquez JJ
    Med Clin (Barc); 1980 Nov; 75(9):398-403. PubMed ID: 7464335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.